Post by
Keeler on Apr 10, 2023 11:34am
Tilray is almost more of an
alcohol company with a cannabis sideline, than a 'cannabis company'.
That 'department' might actually be a postive - but the cannabis side will report no better than all the others in the sector.
I think investors are delusional to think that Hexo's success or failure lies in the fact that they are in a 'master/servant' partnership with Tilray.
Owing Tilray $200 million - is like saying it's good that you have a bank loan for your vehicle, so it's a beneficial partnership. Debt is debt.